For someone who has obesity, type 2 diabetes, or cardiovascular risk factors, a prescription GLP-1 medication could meaningfully reduce their health risks
They can reduce heart-related issues, improve internal health, reduce joint pain, improve mobility, and reduce the risks of obesity-related conditions
For patients with hypothyroidism, hyperthyroidism, or those taking levothyroxine, many clinicians choose to monitor TSH and thyroid hormones more closely during the first months of GLP-1 therapy and as weight changes
Our view: Oral GLP-1 supplementation, combined with good nutrition and consistent habits, is the more evidence-supported non-prescription option
*Please note: reconstitution solutions are sold separately
These gastrointestinal side effects typically peak during weeks 6-8 and resolve significantly by week 12